Marsh (MRSH) Next Earnings Date & Expected ±4.9% Move

Per the Roarable RQD rating, MRSH carries an RQD Score of 80 and a letter grade of B+, labeled "Roarable Buy — Very Good Cash & Smart-Money Inflow." The five pillars are: Fundamental Cash Engine at 16/20 (ROIC 10.6%; FCF yield 5.34%), Whale 13F Flow at 18/20 (institutional accumulation and options positioning), Insider Conviction at 16/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 15/20 (Beta 1.06; sector sensitivity), and Forensic Balance Sheet at 15/20 (Altman Z 2.5; Piotroski F 9/9; Debt/Equity 0.5). The strongest pillar is institutional flow, which is the largest single contributor to the score; the weakest pillars are macro fit and balance sheet, each at 15/20. For a prospective investor, the upside case rests on cash generation and institutional positioning, while the valuation tradeoff is visible in the P/E of 22.5 (TTM) against the forward P/E of 20.9, which implies expected earnings growth is already partly reflected in price. The beta of 1.06 indicates the stock has moved roughly in line with the broader market, so macro-regime sensitivity is present but not extreme. This is an analytical summary of the rating, not personalized advice.

Marsh (MRSH) is a NYSE-listed issuer in the Financials sector, operating within the Specialty Insurers industry, per the company profile. Per the SEC financials, the company generated FY 2025 revenue of $26981.0M. The source data does not describe specific products, customer segments, or revenue-model details beyond the sector and industry classification.

Per the SEC financials, revenue, operating income, net income, and free cash flow rose in each reported period. Per the market data section, operating margin is 23.1%, net margin is 15.4%, and gross margin is 0%. Per the Roarable RQD rating, ROIC is 10.6%, the Altman Z-Score is 2.5, and the Piotroski F-Score is 9/9. Debt declined from $19428.0M in FY 2024 to $18320.0M in FY 2025, and the Debt/Equity ratio is 0.5 per the Roarable RQD rating.

Per the recent news feed, the headlines are predominantly market-wire coverage with a yellow signal, including reports on a possible valuation gap ("Marsh McLennan (MRSH) Stock May Be 37% Undervalued Despite Reinsurance Launch"), a quality-candidate assessment that notes caveats, and a trading-up report. One item is flagged as a green catalyst: an earnings-beat headline suggesting the results could be a game changer for the stock. Risk watch items are limited to the caveat-framed coverage; the feed does not describe specific operational or regulatory risks. Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are recorded.

• What drove the reported FY 2025 earnings beat referenced in the news feed, and what was the EPS figure, given that reported EPS is N/A in the financials?
• Why is gross margin reported as 0%, and does that reflect the business model or a data gap?
• What is the composition of the "reinsurance launch" referenced in the news feed, and how material is it to revenue?
• How do the institutional accumulation and insider cluster flows in the RQD rating reconcile with the absence of holder and analyst data in the source?
• What explains the change in cash between FY 2023 (not available) and FY 2024 and FY 2025?